dp15-1515.pdf

Centers for Disease Control and Prevention

National Center for Chronic Disease Prevention and Health Promotion

Preventing Heart Attacks and Strokes in High Need Areas

CDC-RFA-DP15-1515

Application Due Date: 06/30/2015

Preventing Heart Attacks and Strokes in High Need Areas

CDC-RFA-DP15-1515

TABLE OF CONTENTS

Part I. Overview Information

Federal Agency NameA.

Funding Opportunity TitleB.

Announcement TypeC.

Agency Funding Opportunity NumberD.

Catalog of Federal Domestic Assistance (CFDA) NumberE.

Dates F.

Executive Summary G.

Part II. Full Text

Funding Opportunity Description A.

Award Information B.

Eligibility Information C.

Required Registrations D.

Review and Selection Process E.

Award Administration Information F.

Agency Contacts G.

Other Information H.

Glossary I.

Part I. Overview Information Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Send Me Change Notifications Emails" link to ensure they receive notifications of any changes to CDC-RFA-DP15-1515. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) B. Funding Opportunity Title:

Preventing Heart Attacks and Strokes in High Need Areas C. Announcement Type: New - Type 1 This announcement is only for non-research domestic activities supported by CDC. If research is proposed, the application will not be considered Research for this purpose is defined at http://www.cdc. gov/od/ science / integrity/ docs/cdc- policy- distinguishing- public- health- research- nonresearch. pdf.

This is a Type 2 continuation cooperative agreement for DP10:1013 Mississippi Delta Health Collaborative.

D. Agency Funding Opportunity Number:

CDC-RFA-DP15-1515

E. Catalog of Federal Domestic Assistance (CFDA) Number:

93.283 F. Dates:

1. Due Date for Letter of Intent (LOI): N/A

2. Due Date for Applications: 06/30/2015, 11:59 p.m. U.S.

Eastern Standard Time, at www.grants.gov.

3. Date for Informational Conference Call: N/A

G. Executive Summary:

1. Summary Paragraph:

The Centers for Disease Control and Prevention (CDC) announces the availability of Fiscal Year (FY) 2015 funds to implement funding opportunity announcement (FOA) 15-1515: Preventing Heart Attacks and Strokes in High Need Areas. This is a Type 2 continuation cooperative agreement, which will provide funds for one additional budget year (from September 30, 2015 to September 29, 2016) beyond the previously approved project period (from September 30, 2010 to September 29, 2015) for DP10:1013 Mississippi Delta Health Collaborative. As such, this award will be a continuation of funds intended only for the grantee previously awarded under DP10-1013. Accordingly, financial assistance from this FOA will be provided only to the Mississippi Department of Health / Mississippi Delta Health Collaborative (MDHC). No other applications will be solicited, or will be reviewed.

The purpose of this one-year funding announcement is for MDHC to complete existing activities that aim to prevent heart disease, stroke, and related chronic diseases, and would otherwise not be done because of limited time and funds. This program will continue to intensify collaboration among the Mississippi Department of Health, existing chronic disease programs (e.g., heart disease and stroke prevention, diabetes, tobacco, nutrition, physical activity), local health departments, other community health care providers (e.g., Federally Qualified Health Centers), local communities, and the CDC. MDHC will continue to implement interventions that focus on priority populations across Mississippi's 18-county Delta Region and https://foa.grantsolutions.gov/announcementmodule/www.grants.gov https://foa.grantsolutions.gov/announcementmodule/www.grants.gov http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.grants.gov address "ABCS" (i.e., Aspirin therapy, Blood pressure control, Cholesterol management, Smoking cessation, and Smoke-free ordinances). MDHC will continue to address and/or complete seven key recipient activities:

1) Program Infrastructure, Staffing, Management and Support; 2) Fiscal Management; 3) Leadership Team, Partnership Development, and Maintenance; 4) Implementation of Clinical Interventions; 5) Implementation of Community-Based Educational, Policy, and Systems Interventions; 6) Program Evaluation and Surveillance; and 7) Collaboration with other Chronic Disease Programs.

a. Eligible Applicants: Single

b. FOA Type: Cooperative Agreement

c. Approximate Number of Awards: 1

d. Total Project Period Funding: $3,150,000

e. Average One Year Award Amount: $3,150,000 Includes both direct and indirect costs.

f. Number of Years of Award: 1

g. Estimated Award Date: 09/30/2015

h. Cost Sharing and / or Matching Requirements: N Cost sharing or matching funds are not required for this program.

Part II. Full Text A. Funding Opportunity Description

1. Background

a. Overview

Chronic diseases—including heart disease and stroke —and related risk factors, such as tobacco use, physical inactivity, and poor diet, are the leading causes of death and disability in the United States, accounting for 7 of every 10 deaths. Heart disease, cancer and stroke account for more than 50% of deaths each year. Less than half of people with hypertension have their blood pressure adequately controlled and only one-third of people with high cholesterol have adequately controlled hyperlipidemia. Among those with uncontrolled hypertension, many people (40% or 14 million people) don’t know they have it, and millions more (45% or 16 million people) are taking blood pressure medicines, but still are not under control. Nearly 90% of U.S. adults with uncontrolled hypertension have a usual source of health care and insurance, representing a missed opportunity for hypertension control. Improved hypertension control will require an expanded effort and an increased focus on blood pressure from health care systems, clinicians, and individuals. Eating too much sodium, which most people do, is a major contributor to high blood pressure.

Residents of the 18-county Mississippi Delta Region experience age-adjusted rates of death due to heart disease, stroke, and major CVDs that are considerably higher than Mississippi and national rates. Marked racial health disparities exist, with African American men having the highest rates of heart disease and stroke.

b. Statutory Authorities

This program is authorized under Section 317(k)(2) of the Public Health Service Act (PHS Act), 42 U.S.C.

247b(k)(2) as amended.

c. Healthy People 2020

This program addresses the Healthy People 2010 focus areas of Heart Disease and Stroke (Chapter 12) and Tobacco Use (Chapter 27), to be updated in accordance with Healthy People 2020.

d. Other National Public Health Priorities and Strategies

This program supports strategies to prevent heart disease and stroke, and increase physical activity and healthy eating as outlined in the following national plans and guidance:

The Guide to Community Preventive Services: http://www.thecommunityguide.org/index.html

National Physical Activity Plan: http://www.physicalactivityplan.org

2008 Physical Activity Guidelines for Americans: http://www.health.gov/PAGuidelines/

e. Relevant Work

For several years, CDC's National Center for Chronic Disease Prevention and Health Promotion has provided scientific leadership and technical expertise to state, tribal, local and territorial departments of health to assist them in building capacity to develop, deliver, and implement chronic disease prevention and health promotion programs that have measureable impact.

The Division for Heart Disease and Stroke Prevention has a rich history of working collaboratively with state and local departments of health, including the MS Department of Health / MS Delta Health Collaborative, to increase their ability to carry out public health functions and implement evidence-based strategies to reduce risk factors associated with a variety of chronic diseases.

The approach outlined in this FOA builds on the lessons learned implementing coordinated models intended to maximize CDC’s investment in the work of state and local departments of health.

2. CDC Project Description

a. Approach

N/A

i. Purpose

MDHC will complete existing activities that aim to prevent heart disease, stroke, and related chronic diseases by implementing interventions that focus on priority populations across MS's 18-county Delta Region and address "ABCS" (i.e., Aspirin therapy, Blood pressure control, Cholesterol management, Smoking cessation, and Smoke-free ordinances). MDHC will address and/or complete seven recipient activities: 1) Program Infrastructure, Staffing, Management and Support; 2) Fiscal Management; 3) Leadership Team, Partnership Development, and Maintenance; 4) Implementation of Clinical Interventions; 5) Implementation of Community-Based Educational, Policy, and Systems Interventions; 6) Program Evaluation and Surveillance;

and 7) Collaboration with other Chronic Disease Programs.

http://www.thecommunityguide.org/index.html http://www.physicalactivityplan.org http://www.health.gov/PAGuidelines/ and 7) Collaboration with other Chronic Disease Programs.

ii. Outcomes

Measurable outcomes of the program will be in alignment with the following performance goal which is part of the overall mission of the National Center for Chronic Disease Prevention and Health Promotion:

To reduce death and disability due to heart disease and stroke and eliminate disparities.

ABCS of Heart Disease and Stroke Prevention

The following outcomes address aspirin, hemoglobin A1c (A1C), blood pressure, cholesterol, and smoking:

ASPIRIN

Increase proportion of providers who adhere to current evidence-based aspirin therapy guidelines.

A1C

Increase proportion of population that have diabetes under control as defined by current evidence-based guidelines.

Increase proportion of patients with diabetes with an A1c level less than 7% of total hemoglobin.

Increase proportion of patients who have had A1c level measured within the recommended timeframe.

Increase proportion of population that have diabetes diagnosed based on A1C test.

Increase proportion of people with diabetes who know that they have the condition.

BLOOD PRESSURE

Increase proportion of adults who have achieved blood pressure control as defined by current evidence-based guidelines.

Increase proportion of patients with high blood pressure in compliance with hypertensive medication regimens.

Increase proportion of providers who follow current evidence-based guideline algorithms for pharmacological therapies to treat high blood pressure.

Decrease average blood pressure levels among adults with high blood pressure.

Proportion of individuals/patients on dialysis (Monitoring).

LDL-CHOLESTEROL

Increase proportion of adults screened for blood cholesterol according to current evidence-based guidelines.

Increase proportion of adults diagnosed with high cholesterol who have LDL cholesterol at or below goal as defined by current evidence-based guidelines.

Increase proportion of providers who follow current evidence-based guideline algorithms for pharmacologic therapies to treat high cholesterol.

Decrease average LDL cholesterol level among adults with high cholesterol.

SMOKING/TOBACCO

Increase proportion of adults who have been asked by a health care professional about smoking.

Increase proportion of smokers who have been advised to quit smoking by a health care professional.

Increase proportion of adult and young smokers who have made a quit attempt.

Decrease prevalence of cigarette smoking among adults.

iii. Strategies and Activities

MDHC will work within the 18-county MS Delta Region to continue to implement population-wide and priority population approaches to prevent and control heart disease and stroke, and reduce health disparities associated with heart disease and stroke by addressing and/or completing seven recipient activities:

1) Program Infrastructure, Staffing, Management and Support; 2) Fiscal Management; 3) Leadership Team, Partnership Development, and Maintenance; 4) Implementation of Clinical Interventions; 5) Implementation of Community-Based Educational, Policy, and Systems Interventions; 6) Program Evaluation and Surveillance; and 7) Collaboration with other Chronic Disease Programs.

1.Collaborations

MDHC is required to continue to collaborate with CDC-funded programs as well as other organizations external to CDC. As such, MDHC should leverage resources to ensure that programs provide coherent and coordinated approaches to prevention and improvement of quality of care especially regarding the ABCS. In addition, MDHC should coordinate partners around the use of consistent messaging to create demand for policy and systems change for heart disease and stroke prevention, treatment, and control.

a. With CDC-funded programs:

MDHC must continue to collaborate with other related CDC-funded state and community programs that have a role in achieving the FOA outcomes. Examples of these programs include chronic disease programs within the Department of Health, and across District Health Offices. MDHC must ensure that State and District staff are actively engaging participants.

Potential areas of collaboration include partners, stakeholder groups, data, location of interventions, etc.

b. With organizations external to CDC:

MDHC must continue to collaborate with organizations external to CDC that have a role in achieving FOA outcomes. Examples of these organizations include federally qualified health centers (FQHCs), rural clinics, community-based organizations, etc.

Potential areas of collaboration include sharing data with appropriate privacy protections, engaging in program implementation, reaching priority populations, enhancing communication, etc. For example, the applicant may wish to provide medical equipment (e.g., blood pressure cuffs) to participants as an incentive to increase and sustain adherence to the self-management component of treatment plans. However, purchasing blood pressure cuffs is disallowable with cooperative agreement funds. Therefore, MDHC could leverage its partners to purchase these on its behalf.

2. Target Populations

The seven recipient activities supported through this FOA represent a dual approach that targets the entire population of the 18-county MS Delta Region and specific, selected priority populations of the 18-county MS Delta Region. Priority populations are those who are at high risk or experience a disproportionate burden of heart disease and stroke due to racial/ethnic, socioeconomic or other characteristics, including inadequate access to care, and poor quality of care.

a. Inclusion

N/A

iv. Funding Strategy (for multi-component FOAs only)

N/A

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy

MDHC must (1) report on CDC performance measures as specified in this FOA and (2) develop and implement an evaluation plan that addresses progress on the performance measures. This evaluation approach should provide data on the progress and achievements that MDHC is making toward addressing the prevention and control of heart disease and stroke within the 18-county MS Delta Region.

CDC will work with MDHC to operationalize required performance measures and assist with the identification of sound data collection approaches and/or the availability of existing data collection instruments.

ii. Applicant Evaluation and Performance Measurement Plan

MDHC must provide an evaluation plan that assesses progress towards achieving work plan activities, objectives, and goals that include an overall program logic model which illustrates the relationship between program activities and expected outcomes (e.g., DHDSP Evaluation Guide Logic Models at http://www.cdc .gov/dhdsp). High blood pressure and LDL-cholesterol-related objectives and evaluation measures should be linked to CDC’s short term indicators for policy and system change outcomes (see the Policy and System Outcome Indicators for State Heart Disease and Stroke Prevention Guide at http://www.orau.gov/hsc/hdspi nstitute/2008/presentations/Session13-25-HDSPIndicators.pdf ).

MDHC must submit a report on evaluation findings of the routine monitoring and measurement of key indicators in the following domains: outputs, piolicy or system changes implemented, health outcomes, and economic impact.

c. Organizational Capacity of Awardees to Execute the Approach

MS Delta Health Collaborative must describe its organizational capacity and readiness to implement interventions that focus on priority populations across Mississippi's 18-county Delta Region and address "ABCS" (i.e., Aspirin therapy, A1C [hemoglobin A1c], Blood pressure control, Cholesterol management, Smoking cessation, and Smoke-free ordinances).

MS Delta Health Collaborative must describe how it will address and/or complete seven key recipient activities: 1) Program Infrastructure, Staffing, Management and Support; 2) Fiscal Management; 3) Leadership Team, Partnership Development, and Maintenance; 4) Implementation of Clinical Interventions;

5) Implementation of Community-Based Educational, Policy, and Systems Interventions; 6) Program Evaluation and Surveillance; and 7) Collaboration with other Chronic Disease Programs.

d. Work Plan http://www.cdc.gov/dhdsp http://www.cdc.gov/dhdsp http://www.orau.gov/hsc/hdspinstitute/2008/presentations/Session13-25-HDSPIndicators.pdf http://www.orau.gov/hsc/hdspinstitute/2008/presentations/Session13-25-HDSPIndicators.pdf

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and awardees, site visits, and awardee reporting (including work plans, performance, and financial reporting). Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking awardee progress in achieving the desired outcomes.

Ensuring the adequacy of awardee systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that awardees are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with awardees on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Other activities deemed necessary to monitor the award, if applicable.

These activities may include monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk grantees.

The CDC programs that are involved with this FOA will provide substantial involvement, in ways that are listed below in the next section on "CDC Program Support to Awardees".

f. CDC Program Support to Awardees (THIS SECTION APPLIES ONLY TO COOPERATIVE

AGREEMENTS)

In a cooperative agreement, CDC staff is substantially involved in the program activities above and beyond routine grant monitoring.

CDC activities for this program are as follows:

Provide ongoing programmatic leadership to assure success in addressing the ABCS of heart disease and stroke prevention using evidence-based public health strategies with an emphasis on population-based policy, systems and environmental changes to include the following areas: 1.

Community assessment and planning, 2. Evidence-based and practice-based approaches, 3.

Community mobilization and partnership development, 4. Implementation of broad-based policy, systems, and environmental changes, 5. Pogram sustainability, 6. Evaluation of policy, system, and environmental level change, 7. Monitoring of risk behavior change and longer-term health outcomes.

Support enhancement capacity to collect surveillance data for program planning, implementation and evaluation (e.g., data analysis, statistical and small area analysis, identification of key indicators to track the burden of cardiovascular diseases and status of the ABCS, the impact of interventions, and presentation of key surveillance indicators for the MS Delta on the CDC Data Trends & Maps website).

Foster the transfer of successful evidence and practice-based interventions, program models and other forms of community programmatic support by convening meetings, workshops, web forums, conferences, and conference calls with awardees.

Conduct on-site visits to awardee to ensure achievement of benchmarks and project success as outlined within this FOA.

Coordinate with other Federal agencies and existing place-based revitalization and reform projects funded by the US Government, including community development and livability efforts and activities funded by the Recovery Act.

B. Award Information

1. Funding Instrument Type: Cooperative Agreement CDC's substantial involvement in this program appears in the

CDC Program Support to Awardees Section.

2. Award Mechanism: Coop Agreement

U58 Chronic Disease Prevention and Control Cooperative Agreement

3. Fiscal Year: 2015 Estimated Total Funding: $3,150,000

4. Approximate Total Fiscal Year Funding: $3,150,000

5. Approximate Project Period Funding: $3,150,000

6. Total Project Period Length: 1 year(s)

7. Expected Number of Awards: 1

8. Approximate Average Award: $3,150,000 Per Budget Period

Includes both direct and indirect costs.

9. Award Ceiling: $3,150,000 Per Budget Period

Includes both direct and indirect costs.

10. Award Floor: $3,150,000 Per Budget Period

Includes both direct and indirect costs.

11. Estimated Award Date: 09/30/2015 Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the awardee (as documented in required reports), and the determination that continued funding is in the best interest of the federal government. The total number of years for which federal support has been approved (project period) will be shown in the “Notice of Award.” This information does not constitute a commitment by the federal government to fund the entire period. The total project period comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

12. Budget Period Length: 12 month(s)

13. Direct Assistance Direct Assistance (DA) is available through this FOA.

C. Eligibility Information

1. Eligible Applicants Eligibility Category: State governments

2. Additional Information on Eligibility

This is a Type 2 continuation cooperative agreement, which will provide funds for one additional budget year (from September 30, 2015 to September 29, 2016) beyond the previously approved project period (from September 30, 2010 to September 29, 2015) for DP10:1013 Mississippi Delta Health Collaborative.

As such, this award will be a continuation of funds intended only for the grantee previously awarded under DP10-1013. Accordingly, financial assistance from this FOA will be provided only to the Mississippi Department of Health / Mississippi Delta Health Collaborative (MDHC). No other applications will be solicited, or will be reviewed.

The award ceiling for this FOA is $3,150,000. CDC will consider any application requesting an award higher than this amount as non- responsive and it will receive no further review. If a pre-application is required, then specify here and include it in the special eligibility requirements section. (http:// www.hhs.gov/ asfr/ ogapa/ aboutog/ hhsgps107.pdf)

3. Justification for Less than Maximum Competition

Eligible Applicants: Mississippi Department of Health, Single Eligibility-Sole Source

In Phase One, CDC conducted background community assessments of health and related social and environmental conditions in the 18-county Delta Region of Mississippi. These assessments further clarified the conditions contributing to the disproportionate burden of heart disease and stroke, and related conditions in the Delta as compared to the nation.

During Phase Two, CDC laid the groundwork for the Mississippi Delta Health Collaborative through a planning phase, which included the development of a Strategic Alliance Advisory group and the development of a strategic plan. As part of this phase, community organizations were brought on board to implement evidence-based interventions in healthcare, community, faith-based, worksite, and schools.

Under this FOA, Phase Three of the project is designed to build on lessons learned from Phases One and Two. The program will expand its place-based established framework to implement population-based polices and interventions with community-wide impact on the ABCS of heart disease and stroke prevention. The Mississippi Department of Health is uniquely qualified to achieve public health impact based on the following factors: 1) experience working with CDC to increase the prevention of heart disease, stroke, and related conditions at the State and local level; 2) through its District Health Offices, specifically the Delta Hills Public Health District, and local health departments, there currently exists strong integration across Delta Region communities; and 3) direct engagement of community partners and organizations to promote coordination of public health efforts andsuccessfully facilitate policy, environmental, and systems level changes to promote population-based health. Furthermore, staff hired during Phase Two understand and are familiar with the unique local needs, challenges, assets, regional culture, and are trusted community resources.

4. Cost Sharing or Matching Cost Sharing / Matching Requirement:

No

Cost sharing or matching funds are not required for this program.

http://www.hhs.gov/asfr/ogapa/aboutog/hhsgps107.pdf http://www.hhs.gov/asfr/ogapa/aboutog/hhsgps107.pdf

5. Maintenance of Effort

Maintenance of effort is not required for this program.

D. Required Registrations

Additional materials that may be helpful to applicants: http://www.cdc.gov/od/pgo/funding/docs/Financial ReferenceGuide.pdf.

1. Required Registrations An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

a. Data Universal Numbering System: All applicant organizations must obtain a Data Universal Numbering System (DUNS) number. A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as the Universal Identifier when applying for federal awards or cooperative agreements.

The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or Internet at http:// fedgov.dnb.com/webform/displayHomePage.do. The DUNS number will be provided at no charge.If funds are awarded to an applicant organization that includes sub-awardees, those sub-awardees must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM): The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as an awardee. All applicant organizations must register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC. If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process usually requires not more than five business days, and registration must be renewed annually. Additional information about registration procedures may be found at www.SAM.gov.

c. Grants.gov: The first step in submitting an application online is registering your organization through www.grants.gov, the official HHS E-grant website. Registration information is located at the "Get Registered" option at www.grants.gov.

All applicant organizations must register with www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants must start the registration process as early as possible.

2. Request Application Package Applicants may access the application package at www.grants.gov.

3. Application Package Applicants must download the SF-424, Application for Federal Assistance, package associated with this funding opportunity at www.grants.gov. If Internet access is not available, or if the online forms cannot be accessed, applicants may call the CDC PGO staff at 770-488-2700 or e-mail PGO PGOTIM@cdc.gov for assistance. Persons with hearing loss may access CDC telecommunications at TTY 1-888-232-6348.

4. Submission Dates and Times If the application is not submitted by the deadline published in the FOA, it will not be processed. PGO personnel will notify the applicant that their application did not meet the deadline. The applicant must receive pre-approval to submit a paper application (see Other Submission Requirements section for additional details). If the applicant is authorized to submit a paper application, it must be received by the deadline provided by PGO.

http://www.cdc.gov/od/pgo/funding/docs/FinancialReferenceGuide.pdf http://www.cdc.gov/od/pgo/funding/docs/FinancialReferenceGuide.pdf http://www.grants.gov http://fedgov.dnb.com/webform/displayHomePage.do https://www.SAM.gov http://www.Grants.gov http://www.grants.gov http://www.grants.gov http://www.grants.gov http://www.grants.gov https://foa.grantsolutions.gov/announcementmodule/PGOTIM@cdc.gov%20

a. Letter of Intent Deadline (must be emailed or postmarked by) N/A

b. Application Deadline Due Date for Applications: 06/30/2015, 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov. If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which grants.gov operations resume.

5. CDC Assurances and Certifications All applicants are required to sign and submit “Assurances and Certifications” documents indicated at http://www.cdc.gov/grants/interestedinapplying/applicationprocess.html.

Complete the applicable assurances and certifications on an annual basis, name the file “Assurances and Certifications” and upload it as a PDF file at www.grants.gov Complete the applicable assurances and certifications and submit them directly to CDC on an annual basis at http://wwwn.cdc. gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/ Homepage.aspx

Assurances and certifications submitted directly to CDC will be kept on file for one year and will apply to all applications submitted to CDC by the applicant within one year of the submission date.

6. Content and Form of Application Submission Applicants are required to include all of the following documents with their application package at www.grants.gov.

7. Letter of Intent

LOI is not requested or required as part of the application for this FOA.

8. Table of Contents (No page limit and not included in Project Narrative limit): The applicant must provide, as a separate attachment, the “Table of Contents” for the entire submission package.

Provide a detailed table of contents for the entire submission package that includes all of the documents in the application and headings in the "Project Narrative" section. Name the file "Table of Contents" and upload it as a PDF file under "Other Attachment Forms" at www.grants.gov.

9. Project Abstract Summary (Maximum 1 page)

A project abstract is included on the mandatory documents list and must be submitted at www.grants.gov.

The project abstract must be a self-contained, brief summary of the proposed project including the purpose and outcomes. This summary must not include any proprietary or confidential information. Applicants must enter the summary in the "Project Abstract Summary" text box at www.grants.gov.

10. Project Narrative (Maximum of 20 pages, single spaced, Calibri 12 point, 1-inch margins, number all pages. Content beyond 20 pages will not be considered. The 20 page limit includes the work plan. For a multi-component FOA, maximum page limit is 25.)

The Project Narrative must include all of the bolded headings shown in this section. The Project Narrative must be succinct, self-explanatory, and in the order outlined in this section. It must address outcomes and activities to be conducted over the entire project period as identified in the CDC Project Description section. Applicants must submit a Project Narrative with the application forms. Applicants must name this file “Project Narrative” and upload it at www.grants.gov.

http://www.grants.gov http://www.cdc.gov/grants/interestedinapplying/applicationprocess.html http://www.grants.gov/ http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://www.grants.gov http://www.grants.gov http://www.grants.gov

a. Background Applicants must provide a description of relevant background information that includes the context of the problem (See CDC Background).

b. Approach

i. Purpose Applicants must describe in 2-3 sentences specifically how their application will address the problem as described in the CDC Background section.

ii. Outcomes Applicants must clearly identify the outcomes they expect to achieve by the end of the project period.

Outcomes are the results that the program intends to achieve. All outcomes must indicate the intended direction of change (e.g., increase, decrease, maintain). (See the logic model in the Approach section of the CDC Project Description.)

iii. Strategies and Activities Applicants must provide a clear and concise description of the strategies and activities they will use to achieve the project period outcomes. Applicants must select existing evidence-based strategies that meet their needs, or describe in the Applicant Evaluation and Performance Measurement Plan, how these strategies will be evaluated over the course of the project period. (See CDC Project Description: Strategies and Activities section.)

1. Collaborations Applicants must describe how they will collaborate with programs and organizations either internal or external to CDC.

2. Target Populations Applicants must describe the specific target population(s) in their jurisdiction and explain how such a target will achieve the goals of the award and/or alleviate health disparities. Refer back to the CDC Project Description section – Approach: Target Population.

c. Applicant Evaluation and Performance Measurement Plan Applicants must provide an overall evaluation and performance measurement plan that is consistent with the CDC Evaluation and Performance Measurement Strategy section of the CDC Project Description of this FOA. Data collected must be used for ongoing monitoring of the award to evaluate its effectiveness, and for continuous program improvement.

The plan must:

Affirm the ability to collect the performance measures and respond to the evaluation questions specified in the CDC strategy. (For guidance regarding the Paperwork Reduction Act, please visit http://www.hhs.gov/ocio/policy/collection/infocollectfaq.html) Describe how key program partners will participate in the evaluation and performance measurement planning processes.

Describe how evaluation findings will be used for continuous program quality improvement.

Where the applicant chooses to, or is expected to, take on specific evaluation studies:

Describe the type of evaluation(s) (i.e., process, outcome, or both) to be conducted.

Describe key evaluation questions to be addressed by these evaluations.

Describe other information relevant to the evaluation (e.g., measures, data sources)

Awardees will be required to submit a more detailed evaluation and performance measurement plan within http://www.hhs.gov/ocio/policy/collection/infocollectfaq.html

Awardees will be required to submit a more detailed evaluation and performance measurement plan within the first 6 months of the project, as outlined in the reporting section of the FOA.

d. Organizational Capacity of Applicants to Implement the Approach Applicant must address the organizational capacity requirements as described in the CDC Project Description.

11. Work Plan (Included in the Project Narrative’s 20 page limit)

Applicants must prepare a work plan consistent with the CDC Project Description Work Plan section. The work plan integrates and delineates more specifically how the awardee plans to carry out achieving the project period outcomes, strategies and activities, evaluation and performance measurement.

Applicants must name this file "Work Plan" and upload it as a PDF file at www.grants.gov.

12. Budget Narrative Applicants must submit an itemized budget narrative, which may be scored as part of the Organizational Capacity of Awardees to Execute the Approach. When developing the budget narrative, applicants must consider whether the proposed budget is reasonable and consistent with the purpose, outcomes, and program strategy outlined in the project narrative. The budget must include:

Salaries and wages Fringe benefits Consultant costs Equipment Supplies Travel Other categories Contractual costs Total Direct costs Total Indirect costs

Indirect costs will not be reimbursed under grants to foreign organizations, international organizations, and foreign components of grants to domestic organizations (does not affect indirect cost reimbursement to the domestic entity for domestic activities). The CDC will not reimburse indirect costs unless the recipient has an indirect cost rate covering the applicable activities and period.

For guidance on completing a detailed budget, see Budget Preparation Guidelines at:http://www.cdc.gov/grants/interestedinapplying/applicationresources.html .

If applicable and consistent with the cited statutory authority for this announcement, applicant entities may use funds for activities as they relate to the intent of this FOA to meet national standards or seek health department accreditation through the Public Health Accreditation Board (see: http://www.phaboard.org).

Applicant entities to whom this provision applies include state, local, territorial governments (including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau), or their bona fide agents, political subdivisions of states (in consultation with states), federally recognized or state-recognized American Indian or Alaska Native tribal governments, and American Indian or Alaska Native tribally designated organizations. Activities include those that enable a public health organization to deliver public health services such as activities that ensure a capable and qualified workforce, up-to-date information systems, and the capability to assess and respond to public health needs. Use of these funds must focus on achieving a minimum of one national standard that supports the intent of the FOA. Proposed activities must be included in the budget narrative and must http://www.grants.gov http://www.cdc.gov/grants/interestedinapplying/applicationresources.html http://www.phaboard.org supports the intent of the FOA. Proposed activities must be included in the budget narrative and must indicate which standards will be addressed.

Applicants must name this file “Budget Narrative” and upload it as a PDF file at www.grants.gov. If requesting indirect costs in the budget, a copy of the indirect cost-rate agreement is required. If the indirect costs are requested, include a copy of the current negotiated federal indirect cost rate agreement or a cost allocation plan approval letter for those Grantees under such a plan. Applicants must name this file “Indirect Cost Rate” and upload it at www.grants.gov.

Not applicable.

13. Tobacco and Nutrition Policies Awardees are encouraged to implement tobacco and nutrition policies.

Unless otherwise explicitly permitted under the terms of a specific CDC award, no funds associated with this FOA may be used to implement the optional policies, and no applicants will be evaluated or scored on whether they choose to implement these optional policies.

CDC supports implementing evidence-based programs and policies to reduce tobacco use and secondhand smoke exposure, and to promote healthy nutrition. CDC encourages all awardees to implement the following optional recommended evidence-based tobacco and nutrition policies within their own organizations. The tobacco policies build upon the current federal commitment to reduce exposure to secondhand smoke, specifically The Pro-Children Act, 20 U.S.C. 7181-7184, that prohibits smoking in certain facilities that receive federal funds in which education, library, day care, health care,or early childhood development services are provided to children.

Tobacco Policies:

Tobacco-free indoors: Use of any tobacco products (including smokeless tobacco) or electronic cigarettes is not allowed in any indoor facilities under the control of the awardee.

1.

Tobacco-free indoors and in adjacent outdoor areas: Use of any tobacco products or electronic cigarettes is not allowed in any indoor facilities, within 50 feet of doorways and air intake ducts, and in courtyards under the control of the awardee.

2.

Tobacco-free campus: Use of any tobacco products or electronic cigarettes is not allowed in any indoor facilities or anywhere on grounds or in outdoor space under the control of the awardee.

3.

Nutrition Policies:

Healthy food-service guidelines must, at a minimum, align with HHS and General Services Administration Health and Sustainability Guidelines for Federal Concessions and Vending Operations.

These guidelines apply to cafeterias, snack bars, and vending machines in any facility under the control of the awardee and in accordance with contractual obligations for these services (see: http://www.gsa.gov/ graphics/pbs/Guidelines_for_ Federal_ Concessions_and_Vending _ Operations.pdf).

1.

Resources that provide guidance for healthy eating and tobacco-free workplaces are:2.

http://www.cdc.gov/ nccdphp/dnpao/hwi/ toolkits/ tobacco/index.htm http://www. thecommunityguide.org/ tobacco/index.html http:// www.cdc.gov /obesity /strategies /food-serv-guide.html

14. Health Insurance Marketplaces http://www.grants.gov http://www.grants.gov http://www.gsa.gov/graphics/pbs/Guidelines_for_Federal_Concessions_and_Vending_Operations.pdf http://www.gsa.gov/graphics/pbs/Guidelines_for_Federal_Concessions_and_Vending_Operations.pdf http://www.cdc.gov/nccdphp/dnpao/hwi/toolkits/tobacco/index.htm http://www.thecommunityguide.org/tobacco/index.html http://www.cdc.gov/obesity/strategies/food-serv-guide.html

14. Health Insurance Marketplaces A healthier country is one in which Americans are able to access the care they need to prevent the onset of disease and manage disease when it is present. The Affordable Care Act, the health care law of 2010, creates new Health Insurance Marketplaces, also known as Exchanges, to offer millions of Americans affordable health insurance coverage. In addition, the law helps make prevention affordable and accessible for Americans by requiring health plans to cover certain recommended preventive services without cost sharing.

Outreach efforts will help families and communities understand these new options and provide eligible individuals the assistance they need to secure and retain coverage as smoothly as possible. For more information on the Marketplaces and the health care law, visit: www.HealthCare.gov.

15. Intergovernmental Review

The application is subject to Intergovernmental Review of Federal Programs, as governed by Executive Order 12372, which established a system for state and local intergovernmental review of proposed federal assistance applications. Applicants should inform their state single point of contact (SPOC) as early as possible that they are applying prospectively for federal assistance and request instructions on the state's process. The current SPOC list is available at: http://www.whitehouse.gov/omb/grants_spoc/.

16. Pilot Program for Enhancement of Employee Whistleblower Protections Pilot Program for Enhancement of Employee Whistleblower Protections: All applicants will be subject to a term and condition that applies the terms of 48 CFR section 3.908 to the award and requires that grantees inform their employees in writing (in the predominant native language of the workforce) of employee whistleblower rights and protections under 41 U.S.C. 4712.

17. Funding Restrictions Restrictions that must be considered while planning the programs and writing the budget are:

Awardees may not use funds for research.

Awardees may not use funds for clinical care.

Awardees may use funds only for reasonable program purposes, including personnel, travel, supplies, and services.

Generally, awardees may not use funds to purchase furniture or equipment. Any such proposed spending must be clearly identified in the budget.

Reimbursement of pre-award costs is not allowed.

Other than for normal and recognized executive-legislative relationships, no funds may be used for:

publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before any legislative body

See http:// www.cdc.gov /grants /additional requirements /index.htm l#ar12 for detailed guidance on this prohibition and http://www. cdc.gov/ grants /documents/Anti- Lobbying _Restrictions_ for_CDC_ Grantees_July _2012.pdf

The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project outcomes and not merely serve as a conduit for an award to another party or provider who is ineligible.

http://www.HealthCare.gov http://www.whitehouse.gov/omb/grants_spoc/ http://www.cdc.gov/grants/additionalrequirements/index.html#ar12 http://www.cdc.gov/grants/documents/Anti-Lobbying_Restrictions_for_CDC_Grantees_July_2012.pdf http://www.cdc.gov/grants/documents/Anti-Lobbying_Restrictions_for_CDC_Grantees_July_2012.pdf

Awardee may not use funds for clinical care, clinical supplies, medications, patient rehabilitation, or other costs associated with treatment.

Awardee may not use funds for construction.

18. Other Submission Requirements

a. Electronic Submission: Applications must be submitted electronically at www.grants.gov. The application package can be downloaded at www.grants.gov. Applicants can complete the application package off-line and submit the application by uploading it at www.grants.gov. All application attachments must be submitted using a PDF file format. Directions for creating PDF files can be found at www.grants.gov. File formats other than PDF may not be readable by PGO Technical Information Management Section (TIMS) staff.

Applications must be submitted electronically by using the forms and instructions posted for this funding opportunity at www.grants.gov.

If Internet access is not available or if the forms cannot be accessed online, applicants may contact the PGO TIMS staff at 770- 488-2700 or by e-mail at pgotim@cdc.gov, Monday through Friday, 7:30 a.m.–4:30 p.m., except federal holidays. Electronic applications will be considered successful if they are available to PGO TIMS staff for processing from www.grants.gov on the deadline date.

b. Tracking Number: Applications submitted through www.grants.gov are time/date stamped electronically and assigned a tracking number. The applicant’s Authorized Organization Representative (AOR) will be sent an e-mail notice of receipt when www.grants.gov receives the application. The tracking number documents that the application has been submitted and initiates the required electronic validation process before the application is made available to CDC.

c. Validation Process: Application submission is not concluded until the validation process is completed successfully. After the application package is submitted, the applicant will receive a “submission receipt” e-mail generated by www.grants.gov. A second e-mail message to applicants will then be generated by www.grants.gov that will either validate or reject the submitted application package. This validation process may take as long as two business days. Applicants are strongly encouraged to check the status of their application to ensure that submission of their package has been completed and no submission errors have occurred. Applicants also are strongly encouraged to allocate ample time for filing to guarantee that their application can be submitted and validated by the deadline published in the FOA. Non-validated applications will not be accepted after the published application deadline date.

If you do not receive a “validation” e-mail within two business days of application submission, please contact www.grants.gov. For instructions on how to track your application, refer to the e-mail message generated at the time of application submission or the Applicant User Guide, Version 1.1, page 102.

http:// www.grants.gov /documents /19/18243 /Grantsgov ApplicantUserGuide .pdf /ce754626 -c2aa-44bc- b701 -30a75bf428c8

d. Technical Difficulties: If technical difficulties are encountered at www.grants.gov, applicants should contact Customer Service at www.grants.gov.